There is still some upside potential in this stock.
In hopes of re-establishing its brand, the troubled Canadian drugmaker included a 'vesting accelerator' structure in Joseph Papa's compensation package.

Is Amgen Firming Up? Real Money Pro($)

A fresh rally leg could be on the way if AMGN can remain above the $152 area in the near term. 
A pullback to $90 or even to $80 would not be extreme.
Investors watching 13F portfolioS for investment clues are reminded to look at a fund's whole portfolio before following too closely in its footsteps
A close below $69 will give the bears the upper hand.
IBB must recapture and retest the $270 level to classify it as support.
FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.
Health care has been a pricing business for GE, but William Blair says the industrial giant may soon be turning things around.
AbbVie and Gilead Sciences are worth accumulating in a long and deep bear market for biotech.

Columnist Conversations

And I am usually an optimist by nature.
Ahead of tonight's earnings report Nike is showing a little life.  The stock is up over 2.25% as we enter the...
Yesterday Microsoft tested its 2016 low during day two of a massive selling wave.  On Friday MSFT dropped ove...
FIBOCALL: DOW- Dow Chemical Co. DOW is down 3% today and over 11% since 6/23. DOW is now back to a long term o...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.